Brain, 2010 · DOI: 10.1093/brain/awp322 · Published: January 19, 2010
Traumatic spinal cord injuries disrupt the body's natural barriers, leading to an influx of immune cells that can worsen the initial damage and hinder recovery. This study focuses on understanding how these immune cells behave over both short and long periods after a spinal cord injury. Researchers developed a new method to quickly and accurately track changes in the main types of immune cells in the injured spinal cord using flow cytometry. They monitored these changes daily for the first 10 days and then periodically up to 180 days after the injury. The study revealed that inflammation in the spinal cord occurs in multiple phases. The initial phase involves neutrophils, macrophages/microglia, and T cells, while a later phase, starting after 14 days, involves all three cell types and lasts for up to 180 days after the injury.
Understanding the multiphasic inflammatory response could lead to more effective treatments for spinal cord injury, including cell-based and pharmacological approaches.
The study suggests that the timing of anti-inflammatory treatments is crucial, as blocking inflammation at different phases can have different effects on recovery.
The late phase of inflammation may play a reparative role, highlighting the need to consider the potential benefits of inflammation in the chronic phase of spinal cord injury.